Bruker
Trade Bruker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BRKR
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST).
BRKR Key Statistics
Stock Snapshot
The current Bruker(BRKR) stock price is $49.15, with a market capitalization of 7.47B. The stock trades at a price-to-earnings (P/E) ratio of -325.53 and offers a dividend yield of 37.4%.
As of 2026-01-14, Bruker(BRKR) stock has fluctuated between $48.74 and $50.91. The current price stands at $49.15, placing the stock +0.8% above today's low and -3.4% off the high.
The Bruker(BRKR)'s current trading volume is 1.57M, compared to an average daily volume of 2.55M.
During the past year, Bruker(BRKR) stock moved between $28.53 at its lowest and $63.95 at its peak.
During the past year, Bruker(BRKR) stock moved between $28.53 at its lowest and $63.95 at its peak.
BRKR News
Claim 70% Off TipRanks Premium Bruker ( (BRKR) ) just unveiled an update. In a recent regulatory filing, Bruker clarified that certain information furnished i...
In a regulatory filing, Bruker (BRKR) reports that on January 12, during its scheduled presentation at the 44th Annual J.P. Morgan Healthcare Conference, Bruker...
If you are trying to figure out whether Bruker is attractively priced right now, it helps to compare how the market is treating the stock with what its fundamen...
Analyst ratings
63%
of 16 ratingsMore BRKR News
AbCellera Biologics (ABCL) has drawn fresh attention after settling a dispute with Bruker Corporation that brings in a US$36 million upfront payment plus future...
...
The Bruker Energy & Supercon Technologies (BEST) division of Bruker Corporation (NASDAQ:BRKR) on Friday announced two multi-year supply agreements with global r...
AbCellera Biologics recently resolved a legal dispute with Bruker Corporation, securing a US$36,000,000 upfront payment plus future royalties, and added renowne...